Navigation Links
Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA)
Date:7/9/2008

Additional Research Warranted on Impact of Medicare Modernization Act (MMA) to Avoid Health Care Access Challenges; Data Shows Possibility of Longer Wait Times for Patients in Rural Locations

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- According to a new study released today in the July issue of the Journal of the American Medical Association (JAMA), cancer patients experienced no major changes in their access to quality cancer care following the passage of the Medicare Prescription Drug Improvement and Modernization Act (MMA) of 2003. However, the study does suggest that patients in rural communities tended to have longer wait times to begin chemotherapy treatment after diagnosis, with wait times increased by as much as five days from 2003 to 2006.

"We applaud this study and its conclusions, which are encouraging in that most cancer patients perceived virtually no difference in their care following the passage of the MMA," said Nancy Davenport-Ennis, President and CEO of the National Patient Advocate Foundation (NPAF) -- a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels. "However, the finding that patients in rural areas may have longer wait times is deeply concerning -- and it strengthens NPAF's belief that we must continue research on the MMA's impact in order to ensure patients are not faced with dangerous access challenges while trying to manage this dreadful disease."

The study was led by investigators from the Duke Clinical Research Institute (DCRI) and funded by the Global Access Project (GAP) -- a national independent and neutral collaboration of forty two national healthcare stakeholder groups, organized by NPAF in February 2004 to fund research projects reporting implementation of the MMA into the marketplace and unintended consequences, if any, to patients, providers and healthcare systems. The Duke researchers studied data about Medicare beneficiaries who received chemotherapy for diagnoses of leukemia, lymphoma, breast, lung or colorectal cancer from across the United States. They looked at the distance patients traveled to get their chemotherapy treatments, and the amount of time that lapsed from diagnosis to initiation of chemotherapy. They compared data from 2003, before the MMA took effect, to the data from subsequent years through 2006. They did not examine other quality of care indicators.

When the MMA was signed into law by President Bush in 2003, it was the most comprehensive restructuring of Medicare since its inception in 1965. The law created a prescription drug benefit and provided $25 billion for rural hospitals, but it also significantly reduced Medicare reimbursements to healthcare providers starting January 1, 2005. Cancer care, in particular, was targeted for cuts because legislators considered it to have been overly funded.

"We strive to help cancer patients access convenient, safe and high-quality care -- no matter where they live or what their insurance issues may be," said Davenport-Ennis. "Though the JAMA study overall did not find that cancer patients are being negatively impacted as a result of the MMA, its suggestion of longer wait times for patients in rural areas should be researched further so that we can learn more about the situations these patients are facing -- and, in turn, learn how to best overcome them."

National Patient Advocate Foundation (NPAF) is a national, non-profit organization that is dedicated to the mission of creating avenues of patient access through improved access to, and reimbursement for, evolving therapies, therapeutic agent, and devices through policy and legislative reform at the state and federal levels. Our mission is shaped by the experiences of the patients served through our companion organization, Patient Advocate Foundation.


'/>"/>
SOURCE National Patient Advocate Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases
2. Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product
3. Proposing a New Global Compact for Infectious Diseases
4. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
5. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
6. Signalife and Heart One Global Research Agree to Merge
7. AEGON and Right To Play Announce Global Partnership
8. MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement
9. National Press Club to Host NEWSMAKER Media Briefing on Global Health and the Infections of Poverty - Neglected Tropical Diseases
10. Chronic Kidney Disease Growing Globally
11. TechTeam Global Announces Formation of a Global Pharmaceutical Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year ... be an opportunity for area-residents to celebrate two great years while also familiarizing ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin Harper ... prestigious award honoring the top influencers on RealSelf—the most trusted online destination to ... and clinics. , In 2016, more than 82 million people visited RealSelf to ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established its NAEMT Authorized ... providing Prehospital Trauma Life Support (PHTLS) course scholarships to four medics assigned to ... developed in cooperation with the American College of Surgeons to promote critical thinking ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... awards, now in their 12th year, are among the most prestigious in radiology marketing ... the awards were retooled to recognize achievements in both large budget (over $5,000) and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek Insurance Agencies, ... families and business owners across eastern Michigan, is connecting with the Oxford/Orion FISH ... financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure homeless, hungry, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  Sanderling Ventures, portfolio company, ... a division of Johnson & Johnson. Torax manufactures and ... treatment of gastro-esophageal reflux disease (GERD). The LINK ... technology and the procedure is currently available in ... Torax Medical was founded by Sanderling Ventures, Mayo ...
(Date:3/27/2017)... March 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: ... announced today that AGI-134, an immunotherapy for the treatment of ... Ltd., will be featured at the upcoming American Association ... Washington, DC to be held on April 1-5, ... ...
(Date:3/27/2017)... March 27, 2017 The global ... USD 16.0 billion by 2025, according to a new ... of chronic diseases is anticipated to be responsible for ... thereby widens the scope for growth during the forecast ... population, which is highly susceptible to chronic diseases, is ...
Breaking Medicine Technology: